Skip to main content
. 2020 Dec 23;20(4):442–453. doi: 10.5230/jgc.2020.20.e35

Table 4. Details of No. positive patients.

No. No. of metastatic LNs Regional LNs Station of metastatic LNs Tumor size in preoperative EGD Tumor size in pathology Depth of invasion Differentiation Ulceration LVI ESD indication
1 4 LAP (3b, 4d, 5, 6) 6, 8a, 9 2 6.2 SM2 WD (+) (+) Beyond
2 2 LLC (3b, 5) 1, 6 2 2.8 SM2 PD (−) (+) Beyond
3 2 MGC (4sb, 4d) 4d (RLN) 1.3 2 M SRC (−) (−) Expanded
4 1 LAP (3b, 4d, 5, 6) 6 (RLN) 1.2 0.8 M MD (−) (+) Beyond

LN = lymph node; EGD = esophagogastroduodenoscopy; LVI = lymphovascular invasion; ESD = endoscopic submucosal dissection; LAP = lower anterior or posterior; SM = submucosa; M = mucosa; WD = well differentiated; LLC = lower lesser curvature; PD = poorly differentiated; MGC = middle greater curvature; RLN = regional lymph node; SRC = signet ring cell; MD = moderately differentiated.